Skip to main content

US Senate to vote on President Trump’s fentanyl tariffs on Canada

The United States (US) Senate is expected to vote April 1st on a resolution aimed at blocking US President Donald Trump from using the International Emergency Economic Powers Act to impose a 25 percent tariff on Canada. 

“Fortunately, the National Emergencies Act of 1976 included a provision allowing any senator to force a vote to block emergency powers being abused by the president. I will be pulling that procedural lever to challenge Trump’s Canada tariffs early next week,” Senator Tim Kaine (D-Va.) said in an op-ed published Friday in the Washington Post. 

President Trump declared on Feb. 1, 2025, that the threat posed by fentanyl and undocumented migration from Canada, Mexico and China constituted a national emergency that justified the use of tariffs to pressure the three countries to take action to respond. Since then, President Trump has imposed a 20 percent tariff on imports from China and a 25 percent tariff on imports from Canada and Mexico. 

He subsequently paused the tariffs on Mexican and Canadian goods that comply with the U.S.-Canada-Mexico Agreement (USMCA) rules of origin. However, those tariffs on Canada and Mexico snap back into place next week unless Trump reaches a deal with the countries to further suspend them.

The Senate vote would only end the national emergency with regard to Canada. The vote also would take place one day before Trump is set to announce a new set of “reciprocal” tariffs on potentially all trading partners, including Canada, Mexico and China, as well as others in Europe, Asia and elsewhere.

More detail can be accessed in the Politico.com news article located here: Senate Democrats to force vote next week on Trump's fentanyl tariffs on Canada - Live Updates - POLITICO.

Topic(s)

Hot topics
U.S. Tariffs and Canadian Retaliatory Surtax

Information source

International News Channel
Disclaimer

The foregoing information is provided for informational purposes only and is not intended as, nor should it be considered, professional advice or a substitute for conducting your own thorough research and review. Before making any decisions or taking any action based on the information provided, you should conduct your own independent investigation and/or seek professional advice from a qualified expert in the relevant field. The CSCB disclaims all liability for actions taken or not taken based on the information provided.